These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 190100)

  • 1. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis.
    Lagarde M; Dechavanne M
    Biomedicine; 1977 Apr; 27(3):110-2. PubMed ID: 196696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
    Adams GA; Feuerstein IA
    Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced platelet prostaglandin and cyclic AMP production and a possible intrinsic modulation of platelet function.
    Droller MJ
    Scand J Haematol; 1976 Sep; 17(3):167-78. PubMed ID: 184521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemostatic properties of thrombocytes and their cyclic 3,5-adenosine monophosphate and prostaglandin E2 content during the storage of preserved blood at 4 degrees C].
    Sushkevich GN; Chebotarevskaia LV; Siatkovskiĭ VA
    Probl Gematol Pereliv Krovi; 1982 Jun; 27(6):21-3. PubMed ID: 6287450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.